Myogenin Polyclonal Antibody, RBITC Conjugated, Rabbit

Artikelnummer: BSS-BS-3550R-RBITC
Artikelname: Myogenin Polyclonal Antibody, RBITC Conjugated, Rabbit
Artikelnummer: BSS-BS-3550R-RBITC
Hersteller Artikelnummer: bs-3550R-RBITC
Alternativnummer: BSS-BS-3550R-RBITC-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF, WB
Spezies Reaktivität: Bovine, Human, Mouse, Rat
Konjugation: RBITC
Alternative Synonym: MYF4, myf-4, bHLHc3, Myogenin, Class C basic helix-loop-helix protein 3, Myogenic factor 4, MYOG
Acts as a transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation, cell cycle exit and muscle atrophy. Essential for the development of functional embryonic skeletal fiber muscle differentiation. However is dispensable for postnatal skeletal muscle growth, phosphorylation by CAMK2G inhibits its transcriptional activity in respons to muscle activity. Required for the recruitment of the FACT complex to muscle-specific promoter regions, thus promoting gene expression initiation. During terminal myoblast differentiation, plays a role as a strong activator of transcription at loci with an open chromatin structure previously initiated by MYOD1. Together with MYF5 and MYOD1, co-occupies muscle-specific gene promoter core regions during myogenesis. Cooperates also with myocyte-specific enhancer factor MEF2D and BRG1-dependent recruitment of SWI/SNF chromatin-remodeling enzymes to alter chromatin structure at myogenic late gene promoters. Facilitates cell cycle exit during terminal muscle differentiation through the up-regulation of miR-20a expression, which in turn represses genes involved in cell cycle progression. Binds to the E-box containing (E1) promoter region of the miR-20a gene. Plays also a role in preventing reversal of muscle cell differentiation. Contributes to the atrophy-related gene expression in adult denervated muscles. Induces fibroblasts to differentiate into myoblasts (By similarity).
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 4656
UniProt: P15173
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human MYOG/Myogenin
Target-Kategorie: Myogenin
Application Verdünnung: WB(WB=1:500-2000), IF(IF=1:100-500)